Harmful algal blooms (HABs) can have severe ecological, economical, and human health impacts. At least 32 states have reported human or mammal exposures to HAB toxins. Furthermore, studies suggest that the frequency and intensity of HAB events have increased over the past few decades and will continue to increase this century. Knowledge gaps remain regarding the ecological drivers of these events which have hindered the development of successful mitigation strategies. Most HABs are comprised of several genera with each species containing toxic and non-toxic strains. This has made understanding the ecology of these events using traditional methods extremely difficult. Advances in molecular techniques (e.g. quantitative PCR) have facilitated the first steps towards a deeper understanding of these complex events although previous studies have generally focused on a single organism. The investigators'goal is to develop and employ a """"""""flexible"""""""" real-time multiplex quantitative polymerase chain reaction (MqPCR) assay for the simultaneous quantification of co-occurring toxic HAB genera. This will facilitate the next important step in furthering our understanding of these complex events and will significantly improve the integration of HAB activities into existing state and federal monitoring and observational programs. The investigators have four primary objectives: 1) Develop MqPCR specific TaqMan primers and probes for the detection of anatoxin-a producing cyanobacteria as well as toxic eugleniods to incorporate into the existing MqPCR method. 2) Design and field validate a """"""""flexible"""""""" MqPCR that can be tailored to specific HAB events. By designing both TaqMan primers and probes to be replicated in the same thermal cycling program, they will be able to select specific primer sets to match different bloom situations. 3) The investigators will use the MqPCR to investigate the response of microcystin/nodularin-, cylindrospermopsin-, saxitoxin-, and anatoxin-a-producing cyanobacteria as well as potentially toxic euglenoids to environmental variables individually, as well as in relation to each other, over the course of a bloom. They will sample from four sites across the nation each year that routinely develop dense blooms of mixed genera;western Lake Erie, Grand Lake St. Marys, OH, St. Johns River, FL, and Nueces River, TX. Samples will be collected weekly before, during and after bloom events (150 field samples minimum). The investigators will also collect nutrient data, physiochemical parameters and algal toxin data. 4) Identify the role of poorly understood toxin-producing algae with U.S. freshwaters. The three investigators (2 faculty members, one post-doctoral researcher) and a co-investigator's vast expertise in a number of disciplines (microbiology, genetics, and chemistry) will allow for a multi-disciplinary approach toward this research. The MqPCR technique developed will be a valuable tool for the rapid monitoring of HAB genera that can be applied across the marine- freshwater continuum. This study will provide important data for the modeling and prediction of future HAB events as well as the development of early warning networks to protect humans from exposure to HAB toxins. Public Health Relevance: Algal blooms cause serious water quality and human health issues;however, their ecology remains poorly understood. Using a cutting-edge genetic method the investigators will further their understanding of the environmental factors promoting these toxic algae. This will allow for the further development of successful predictive models and algal remediation strategies that will help protect humans from the negative human health effects of algal toxin exposure.

Public Health Relevance

Algal blooms cause serious water quality and human health issues;however, their ecology remains poorly understood. Using a cutting-edge genetic method the investigators will further their understanding of the environmental factors promoting these toxic algae. This will allow for the further development of successful predictive models and algal remediation strategies that will help protect humans from the negative human health effects of algal toxin exposure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES021968-02
Application #
8554364
Study Section
Special Emphasis Panel (ZES1-LKB-J (R2))
Program Officer
Tyson, Frederick L
Project Start
2012-09-24
Project End
2014-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
2
Fiscal Year
2013
Total Cost
$66,019
Indirect Cost
$3,960
Name
Lake Superior State University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
074787789
City
Sault Sainte Marie
State
MI
Country
United States
Zip Code
49783
Bertin, Matthew J; Wahome, Paul G; Zimba, Paul V et al. (2017) Trichophycin A, a Cytotoxic Linear Polyketide Isolated from a Trichodesmium thiebautii Bloom. Mar Drugs 15:
Bertin, Matthew J; Roduit, Alexandre F; Sun, Jiadong et al. (2017) Tricholides A and B and Unnarmicin D: New Hybrid PKS-NRPS Macrocycles Isolated from an Environmental Collection of Trichodesmium thiebautii. Mar Drugs 15:
Zimba, Paul V; Huang, I-Shuo; Gutierrez, Danielle et al. (2017) Euglenophycin is produced in at least six species of euglenoid algae and six of seven strains of Euglena sanguinea. Harmful Algae 63:79-84
Zimba, Paul V; Huang, I-Shuo; Foley, Jennifer E et al. (2017) Identification of a new-to-science cyanobacterium, Toxifilum mysidocida gen. nov. & sp. nov. (Cyanobacteria, Cyanophyceae). J Phycol 53:188-197
Gutierrez, Danielle B; Fahlman, Andreas; Gardner, Manuela et al. (2015) Phosphatidylcholine composition of pulmonary surfactant from terrestrial and marine diving mammals. Respir Physiol Neurobiol 211:29-36
O'Neill, Ellis C; Trick, Martin; Hill, Lionel et al. (2015) The transcriptome of Euglena gracilis reveals unexpected metabolic capabilities for carbohydrate and natural product biochemistry. Mol Biosyst 11:2808-20
Wahome, Paul G; Beauchesne, Kevin R; Pedone, Anna C et al. (2014) Augmenting anti-cancer natural products with a small molecule adjuvant. Mar Drugs 13:65-75